MEDADVISOR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.26 AUD | +1.96% |
|
0.00% | +20.93% |
| Feb. 29 | MedAdvisor Reports Higher Attributable Profit, Revenue in Fiscal H1 | MT |
| Feb. 28 | MedAdvisor Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Companyâs segments include Australia, the United States, the United Kingdom and Asia Operations. The Companyâs products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Companyâs subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.26
AUD
Average target price
0.4033
AUD
Spread / Average Target
+55.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.93% | 90.34M | |
| +3.04% | 32.2B | |
| +7.44% | 6.87B | |
| +15.28% | 3.66B | |
| -10.66% | 3.37B | |
| -26.04% | 1.25B | |
| -40.17% | 1.06B | |
| +0.92% | 888M | |
| -42.60% | 819M | |
| -27.55% | 813M |
- Stock Market
- Equities
- MDR Stock
- News MedAdvisor Limited
- Medadvisor : Raises Fiscal H1 Revenue Guidance for US Subsidiary Adheris
